Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis

Published on Mar 1, 2019in Acta Diabetologica3.00
· DOI :10.1007/s00592-018-1253-5
Lorenzo M. Vetrone1
Estimated H-index: 1
(Leicester General Hospital),
Francesco Zaccardi24
Estimated H-index: 24
(Leicester General Hospital)
+ 5 AuthorsKamlesh Khunti66
Estimated H-index: 66
(Leicester General Hospital)
Aims To investigate cardiovascular disease and mortality trends in control arm participants of diabetes cardiovascular outcome trials (CVOTs).
  • References (29)
  • Citations (2)
#1Claire Fitzpatrick (University of Leicester)H-Index: 1
#2Sudesna Chatterjee (University of Leicester)H-Index: 9
Last.Kamlesh Khunti (NIHR: National Institute for Health Research)H-Index: 66
view all 7 authors...
#1Francesco Zaccardi (Leicester General Hospital)H-Index: 24
#2Nafeesa N. Dhalwani (Leicester General Hospital)H-Index: 7
Last.Kamlesh Khunti (Leicester General Hospital)H-Index: 66
view all 5 authors...
#1William T. Cefalu (American Diabetes Association)H-Index: 33
#2Sanjay Kaul (Cedars-Sinai Medical Center)H-Index: 27
Last.Matthew C. Riddle (OHSU: Oregon Health & Science University)H-Index: 54
view all 13 authors...
#1Aidin Rawshani (University of Gothenburg)H-Index: 6
#2Araz Rawshani (University of Gothenburg)H-Index: 14
Last.Soffia Gudbjörnsdottir (University of Gothenburg)H-Index: 40
view all 10 authors...
#1Merrill Singer (UConn: University of Connecticut)H-Index: 45
#2Nicola Bulled (WPI: Worcester Polytechnic Institute)H-Index: 6
Last.Emily Mendenhall (Georgetown University)H-Index: 16
view all 4 authors...
#1Rachel E. Sherman (FDA: Food and Drug Administration)H-Index: 10
#2Steven A. Anderson (FDA: Food and Drug Administration)H-Index: 13
Last.Robert M. Califf (FDA: Food and Drug Administration)H-Index: 8
view all 15 authors...
#1Francesco Zaccardi (University of Leicester)H-Index: 24
#2Melanie J. Davies (University of Leicester)H-Index: 82
Last.Kamlesh Khunti (University of Leicester)H-Index: 66
view all 8 authors...
View next paperCardiovascular outcome trials in type 2 diabetes: A critical analysis